Company Monitoring Page for Halozyme

latest headlines for company on cafepharma

FDA Updates PDUFA Date of BLA for Subcutaneous Nivolumab in Advanced or Metastatic Solid Tumors
Onc Live
Tue, 05/21/24 - 07:15 pm
Tags:
FDA, Bristol Myers Squibb, Opdivo, Halozyme, solid tumors
BMS, Halozyme score with subcutaneous version of Opdivo
Fierce Pharma
Thu, 10/19/23 - 10:42 pm
Tags:
Bristol Myers Squibb, Halozyme, Opdivo, clinical trials
Roche hits FDA delay with subcutaneous version of Tecentriq amid manufacturing process changes
Fierce Pharma
Thu, 09/7/23 - 10:53 pm
Tags:
Roche, FDA, Tecentriq, Halozyme
Focus: Drugmakers go under the skin, skirting early US Medicare price negotiations
Reuters
Mon, 07/31/23 - 10:12 am
Tags:
injectables, cancer, JNJ, Bristol Myers Squibb, Halozyme, drug pricing
Biopharma's stock market winners of 2022 revealed
EP Vantage
Wed, 01/18/23 - 09:46 am
Tags:
pharma stocks, Merck, Eli Lilly, AbbVie, Daiichi Sankyo, Vertex Pharmaceuticals, Takeda, Sarepta Therapeutics, Halozyme, Horizon Therapeutics
If at first... pharma’s most drawn-out development timelines revealed
EP Vantage
Thu, 11/3/22 - 10:54 am
Tags:
Kyowa Kirin, Takeda, Eiger BioPharmaceuticals, AstraZeneca, Teva Pharmaceutical, Bavarian Nordic, Halozyme, Novartis, MannKind, drug development
The Big Winner With Johnson & Johnson's Recent FDA Approval
Motley Fool
Fri, 07/23/21 - 10:53 am
Tags:
JNJ, FDA, Darzalex Faspro, Halozyme
Pair of R&D updates bolster GSK ahead of investor meeting
Pharmaforum
Tue, 06/22/21 - 10:52 am
Tags:
GSK, COVID-19, sotrovimab, Halozyme, investors
J&J’s next-gen Darzalex sparks drug delivery royalties battle
Fierce Pharma
Thu, 09/24/20 - 11:32 pm
Tags:
JNJ, Darzalex, Genmab, Halozyme
After Ending Cancer Drug Program, Halozyme Predicts Profits in 2020
Xconomy
Tue, 01/21/20 - 11:40 pm
Tags:
Halozyme, clinical trials, drug delivery, Enhanze
Halozyme drops PFS co-primary endpoint from PEGPH20 phase 3
Fierce Biotech
Tue, 11/27/18 - 11:35 pm
Tags:
Halozyme, clinical trials, PEGPH20, metastatic prostate cancer
Halozyme, Inovalon, and Teva Soared This Week: Can They Go Higher?
Motley Fool
Sat, 09/16/17 - 12:05 pm
Tags:
Halozyme, Inovalon, Teva Pharmaceutical, Unitedhealthcare Group, Roche, Bristol-Myers Squibb
Bristol To Pay Halozyme $105 Million To Make New Cancer Drugs Easier To Take
Forbes
Thu, 09/14/17 - 09:58 am
Tags:
Bristol-Myers Squibb, Halozyme, Opdivo
Halozyme Cancer Drug Does Well in Phase 2
Investopedia
Fri, 01/6/17 - 10:13 am
Tags:
Halozyme, pancreatic cancer, clinical trials, PEGPH20, Eli Lilly, Celgene, gemcitabine, Abraxane
AbbVie Ends Halozyme Development Deal
Investopedia
Tue, 11/22/16 - 09:43 pm
Tags:
AbbVie, Halozyme, tnf-alpha, drug development, drug delivery
Halozyme shares drop after AbbVie punts a failed program; Celgene buys another cancer drug
Endpoints
Mon, 11/21/16 - 11:27 am
Tags:
Halozyme, AbbVie, Celgene, marizomib
Halozyme Therapeutics reports 3Q loss
Yahoo/AP
Mon, 11/7/16 - 09:24 pm
Tags:
earnings, Halozyme
FDA Accepts Genentech's Biologics License Application For Subcutaneous Formulation Of Rituximab
Yahoo
Fri, 11/4/16 - 09:18 am
Tags:
FDA, Genentech, Halozyme, rituximab, blood cancer
3 Top Biopharma Movers of the Past Week
24/7 Wall St
Sun, 03/6/16 - 11:31 am
Tags:
Vitae, Juno Therapeutics, Halozyme
Halozyme Therapeutics beats 4Q profit forecasts
Yahoo/AP
Mon, 02/29/16 - 11:58 pm
Tags:
Halozyme, earnings

Pages

last 30 twitter posts

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.